Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
24,328,020
-
Shares change
-
-640,501
-
Total reported value, excl. options
-
$251,022,226
-
Value change
-
-$6,427,620
-
Put/Call ratio
-
207%
-
Number of buys
-
62
-
Number of sells
-
-47
-
Price
-
$10.32
Significant Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) as of Q3 2022
169 filings reported holding AVXL - ANAVEX LIFE SCIENCES CORP. - COM NEW as of Q3 2022.
ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,328,020 shares
.
Largest 10 shareholders include BlackRock Inc. (5,314,177 shares), STATE STREET CORP (4,361,438 shares), VANGUARD GROUP INC (4,105,995 shares), GEODE CAPITAL MANAGEMENT, LLC (1,325,928 shares), NORTHERN TRUST CORP (715,110 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (542,859 shares), CITADEL ADVISORS LLC (467,906 shares), Pier Capital, LLC (384,811 shares), RENAISSANCE TECHNOLOGIES LLC (367,100 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (362,317 shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.